CFAP300
Cilia- and flagella-associated protein 300
Also known as: C11orf70, CF300_HUMAN, DNAAF17, FBB5, MGC13040
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRQ4
- Gene
- CFAP300
- Ensembl
- ENSG00000137691
- Chromosome
- 11
- Canonical length
- 267 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Primary cilium,Centrosome
OverviewNCBI Gene
Predicted to be located in cytoplasm and motile cilium. Implicated in primary ciliary dyskinesia 38. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
267 residues, UniProt reviewed canonical sequence.
>Q9BRQ4|CFAP300
1 MATGELGDLG GYYFRFLPQK TFQSLSSKEI TSRLRQWSML GRIKAQAFGF DQTFQSYRKD
61 DFVMAFFKDP NVIPNLKLLS DSSGQWIILG TEVKKIEAIN VPCTQLSMSF FHRLYDEDIV
121 RDSGHIVKCL DSFCDPFLIS DELRRVLLVE DSEKYEIFSQ PDREEFLFCL FKHLCLGGAL
181 CQYEDVISPY LETTKLIYKD LVSVRKNPQT KKIQITSSVF KVSAYDSAGM CYPSAKNHEQ
241 TFSYFIVDPI RRHLHVLYHC YGVGDMSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CFAP300 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- testis: 28 nTPM
- fallopian tube: 27 nTPM
- choroid plexus: 23 nTPM
- epididymis: 10 nTPM
- seminal vesicle: 6.2 nTPM
- cervix: 5.1 nTPM
Single-cell type
- late primary spermatocytes: 554 nCPM
- respiratory ciliated cells: 340 nCPM
- early spermatids: 317 nCPM
- fallopian tube ciliated cells: 228 nCPM
- early primary spermatocytes: 172 nCPM
- endometrial ciliated cells: 157 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.2 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 21 nTPM
- midbrain: 13 nTPM
- medulla oblongata: 11 nTPM
- spinal cord: 8.5 nTPM
- white matter: 6.4 nTPM
- pons: 5.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CFAP300.
Disease | AllUniProt
Conditions CFAP300 is implicated in, by any mechanism.
- Ciliary dyskinesia, primary, 38 (CILD38) MIM:618063
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 122 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ciliary dyskinesia, primary, 38
- CFAP300-related disorder
- Primary ciliary dyskinesia
- Heterotaxy
- Melanoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cilia- and flagella-associated protein 300
- Cilia- and flagella-associated protein 300
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CFAP300 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CFAP300 as an antibody target. Whether an autoantibody or antibody against CFAP300 could matter depends on whether native CFAP300 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CFAP300 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CFAP300 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...